1.Mahon CR, Manoselis G. Textbook of diagnostic microbiology. 2ⁿᵈ ed. New York: WB. Saunders Company; 2015. P. 15-158.
2. Rappé MS, Giovannoni SJ. The uncultured microbial majority. Ann Rev Microbiol. 2017; 57(3):369-94.
3. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance-a perspective: report Task Force 6. Rev Infect Dis. 1987; 9(3):S297-312.
4. Chawla R, Arora A, Parameswaran MK, Chan P, Sharma D, Michael S, et al. Synthesis of novel 1,3,4- oxadiazole derivatives as potential antimicrobial agents. Acta Pol Pharm. 2010; 67(3):247-53.
5. Adelstein GW, Yen CH, Dajani EZ, Bianchi RG. 3, 3- Diphenyl-3-(2-alkyl-1, 3, 4-oxadiazol-5-yl) propylcy cloalkylamines, a novel series of antidiarrheal agents. J Med Chem. 1976; 19(10):1221-5.
6. Sangshetti JN, Chabukswar AR, Shinde DB. Microwave assisted one pot synthesis of some novel 2,5-disubstituted 1,3,4-oxadiazoles as antifungal agents. Bioorg Mad Chem Lett. 2011; 21(1):444-8.
7. Othman AA, Kihel K, Amara S. 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian J Chem. 2014; 23:1878.
8. Morjan RY, Mkadmh AM, Beadham I, Elmanama AA, Mattar MR, Raftery J, et al. Antibacterial activity of novel nicotinic acid hydrazides and their conversion into N-acetyl-1,3,4-oxadiazoles. Bioorg Med Chem Lett. 2014; 24(24):5796-800.
9. Ravindra KC, Vagdevi HM, Vaidya VP, Padmashali B. Synthesis, anti-microbial and anti-inflammatory activities of 1,3,4-oxadiazoles linked to naphtho [2,1- b] furan. Indian J Heterocyc. Chemist. 2006; 45(4): 2506-11.
10. Nailesh J, Korgaokar S, Parekh H. Synthesis and antimicrobial activity of substituted 1,3,4-oxadiazoles. Indian J Heterocyc Chem. 1996; 5(3):241-2.
11. Rai NP, Narayanaswamy VK, Shashikanth S, Arunachalam PN. Synthesis characterization and antibacterial activity of 2-[1 (5-chloro-2-methoxyphenyl)-5-methyl-1H-pyrazol-4-yl]-5. substitutedphenyl)-[1,3,4] oxadiasoles. Eur J Med Chem. 2009;
44(3):4522-7.
12. Hedrick JL, Twieg R. Poly (aryl ether oxadiazoles). Macromolecules. 1992; 25(7):2021-5.
13. Ciccarelli FD, Doerks T, von Mering C, Creevey CJ, Snel B, Bork P. Toward automatic reconstruction of a highly resolved tree of life. Science. 2006; 56(6):1283-7.
14. Gurupadaswamy HD, Girish V, Kavitha CV, Raghavan SC, Khanum SA. Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents. Eur J Med Chem. 2013; 63: 536-43.
15. Gupta K. Addressing antibiotic resistance. Dis Mon.2003; 49(2):99-110.
16. Liss RH, Batchelor FR. Economic evaluations of antibiotic use and resistance-a perspective: report. Rev Infect Dis. 1987; 9(3):297-312.
17. Souldozi A, Shojaei SH, Ramazani A, Slepokurad K, Lisd T. Synthesis and crystal structure of N-(2-(1,3,4- oxadiazol-2-yl) phenyl)-2,3-dimethylaniline. Chinese J Struct Chem Rep. 2014; 5(2):407-14.
18. Kitao T, Tada T, Tanaka M, Narahara K, Shimojima M, Shimada K, et al. Emergence of a novel multidrugresistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC (6')-Iae in Japan. Int J Antimicrob Agents. 2012; 39(6):518-21.
19. Yousaf M, Zahoor AF, Faiz S, Javed S, Irfan M. Recent synthetic approaches towards biologically potent derivatives/analogues of theophylline. J Heterocyc Chem. 2018; 21(3):842-51.
20. Shridhar AH, Keshavayya J, Hoskeri J. Synthesis, characterization and pharmacological studies of novel bis-1,3,4-oxadiazole and 1,2,4-triazole derivatives. Der Chem Sinica. 2011; 2(4):106-14.
21. Mahajan P, Nikam M, Chate A, Nimbalkar U, Patil V, Bobade A, et al. Synthesis, antioxidant, antiinflammatory, and antimicrobial screening of newer thiophene-fused arylpyrazolyl 1,3,4-oxadiazoles. Phosph Sulfur Silicon Relat Elements. 2015;
190(11):256-65.
22. Khalilullah H, Ahsan MJ, Hedaitullah M, Khan S, Ahmed B. 1,3,4-oxadiazole: a biologically active scaffold. Mini Rev Med Chem. 2012; 12(8):789-801.
23. Lhermie G, Gröhn YT, Raboisson D. Addressing antimicrobial resistance: an overview of priority actions to prevent suboptimal antimicrobial use in food-animal production. Frontiers Microbiol. 2017; 7:2114.
24. Hou L, Shi Y, Zhai P, Le G. Antibacterial activity and in vitro anti-tumor activity of the extract of the larvae of the housefly (Musca domestica). J Ethnopharmacol. 2007; 111(2):227-31.
25. Amoo S, Ndhlala AR, Finnie JF, Van Staden J. Antibacterial, antifungal and anti-inflammatory properties of Burchellia bubaline. South Afr J Botany. 2009; 75(4):60-3. 26. Alipour E, Mousavi Z, Safaei Z, Pordeli M, Safavi M, Firoozpour L, et al. Synthesis and cytotoxic evaluation of some new [1,3]dioxolo[4,5-g]chromen-8-one derivatives. Daru. 2014; 22:41.
27. Mobasheri H, Mahdiuni H, Shafiee A, Foroumadi A. Effects of novel antituberculosis agents on OmpF channel activity. Biochem Biophys Res Commun. 2008; 376(1):174-9.
28. Sonar VN, Yadav LD, Sandhya S. New Mannich bases from oxadiazolyl indoles and their antibacterial activities. Indian J Heterocyc Chem. 1995; 4:203-5.
29. Mogilaiah K, Prashanthi M. Convenient synthesis of 5-aryl-2- [p-(1, 8-naphthyridin-2yl) phenoxymethyl]- 1,3,4-oxadiazoles under microwave irradiation. Indian J Heterocyc Chem. 2000; 14(3):185-8.
30. Maslat AO, Abussaud M, Tashtoush H, Al-Talib M. Synthesis, antibacterial, antifungal and genotoxic activity of bis-1,3,4-oxadiazole derivatives. Pol J Pharmacol. 2002; 54(1):55-9.
31. Mayekar AN, Yathirajan HS, Narayana B, Sarojini BK, Kumari NS. Synthesis and antimicrobial studies on new substituted 1,3,4‐oxadiazole derivatives bearing 6‐bromonaphthalene moiety. Int J Chem. 2010; 2(1):38-54.
32. Prakash O, Kumar M, Kumar R, Sharma C, Aneja KR. Hypervalent iodine (III) mediated synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents. Eur J Med Chem. 2010; 45(9):4252-7.
33. Bhardwaj N, Saraf SK, Sharma P, Kumar P. Syntheses, evaluation and characterization of some 1, 3, 4-oxadiazoles as antimicrobial agents. J Chem. 2009; 6(4):1133-8.
34. Husain A, Ajmal M. Synthesis of novel 1, 3, 4- oxadiazole derivatives and their biological properties. Acta Pharm. 2009; 59(2):223-33.
)